ArticleAmerican journal of preventive cardiology2022

The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl.

Catherine G Derington et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.